Author Archives: Alina Peon
Dalton Partner Discusses AI “Bubble” Debate at Salesforce Annual Conference
Dalton Investments Partner Owens Huang was featured in Central News Agency (CNA) Taiwan’s coverage of Salesforce’s annual Dreamforce conference in San Francisco, where he commented on ongoing debate surrounding whether AI has entered a “bubble” phase. Mr. Huang argued that …
read more >
Sanae Takaichi’s Historic LDP Victory: Political Milestone and Market Response
Sanae Takaichi’s historic election as LDP leader sets the stage for Japan’s first female prime minister, promising political stability and policy continuity. Her conservative approach and support for Abenomics have boosted market confidence, with the Nikkei surging nearly 5%. Dalton …
read more >
Statement Regarding the Decline in Aska Pharmaceutical Holdings’ Share Price
The share price of Aska Pharmaceutical Holdings (“Aska”) has declined significantly following the September 30 release titled “Notice Regarding the Termination of Procedures Based on the Policy for Responding to Large-Scale Purchases of the Company’s Shares, etc., in Connection with …
read more >
Dalton Chief Investment Officer Interviewed by Nikkei Business on Why Poison Pills Do Not Work
Dalton CIO, James B. Rosenwald III, recently interviewed with Nikkei Business, discussing recent announcements by Aska Pharmaceutical and Bunka Shutter to potentially implement a poison pill in order to block shareholder efforts to have each company consider going private. The …
read more >
Dalton Responds to Aska’s Threat of a Poison Pill
On September 30th, 2025, Dalton Investments (“Dalton”) sent a letter to Aska Pharmaceutical addressing its objections to considering a management buyout and the threat that it would enact a poison pill if Dalton increased its ownership level to 30%. Excerpts …
read more >
Dalton Investments Highlighted in “Diligent Market Intelligence: Shareholder Activism in Asia 2025 Report”
In their report “Diligent Market Intelligence: Shareholder Activism in Asia 2025”, Diligent highlights Dalton as one of “Asia’s top activist investors”. When the activity of Dalton Investments and its affiliate company Rising Sun Management (through the closed end fund Nippon …
read more >
Dalton Sends Letter to Aska Pharmaceuticals Holdings and Bunka Shutter Criticizing their Potential Use of Poison Pills
Dalton Investments, a major shareholder of Aska Pharmaceuticals and Bunka Shutter, has sent a letter to both companies criticizing their adoption of a “Response Policy on Large-Scale Purchase of Shares”. The letter outlines four key points of Dalton’s position. Read …
read more >
Dalton Blasts Japan’s Aska Pharma, Bunka Shutter for Takeover Defenses
Dalton Investments’ response to the anti-takeover measures adopted by Aska Pharma and Bunka Shutter—two companies in which it is a major shareholder—was recently featured in Nikkei Asia. Read the article here.
Japan’s Upper House Election Update
Shiro Hayashi, Director of Research and Head of Dalton’s Tokyo research office, discusses the recent House of Councillors (Upper House) election in Japan, where the Liberal Democratic Party (LDP) and its coalition partner Komeito suffered a second consecutive defeat. Read …
read more >
Implementation of Fuji Media Holdings’ Reform Action Plan and Introduction of Takeover Defense Measures Against the Murakami Fund
Rising Sun Management, an affiliate of Dalton, has sent a letter to Fuji Media Holdings regarding the implementation of a reform action plan and the introduction of takeover defense measures against the Murakami Fund. Read the letter here. This document …
read more >